Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 633,059 | 530,181 | 486,195 | 683,287 | 247,939 |
| Marketable Securities | 1,696,145 | 1,818,435 | 1,897,892 | 1,816,257 | 1,972,891 |
| Receivables | 38,977 | 27,834 | 28,605 | 63,034 | 49,077 |
| Inventories | 22,172 | 23,722 | 22,885 | 18,180 | 19,375 |
| Other current assets | 146,628 | 131,015 | 122,468 | 139,839 | 118,809 |
| TOTAL | $2,536,981 | $2,531,187 | $2,558,045 | $2,720,597 | $2,408,091 |
| Non-Current Assets | |||||
| PPE Net | 181,518 | 172,618 | 163,952 | 153,651 | 148,717 |
| Intangibles | 28,274 | 27,700 | 26,750 | 25,674 | 26,985 |
| Other Non-Current Assets | 348,928 | 347,445 | 342,166 | 333,190 | 311,196 |
| TOTAL | $558,720 | $547,763 | $532,868 | $512,515 | $486,898 |
| Total Assets | $3,095,701 | $3,078,950 | $3,090,913 | $3,233,112 | $2,894,989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,849 | 4,966 | 4,150 | 2,026 | 2,060 |
| Accounts payable and accrued liabilities | 16,222 | 7,407 | 21,174 | 16,067 | 13,146 |
| Accrued Expenses | 109,140 | 90,624 | 78,944 | 104,126 | 77,019 |
| TOTAL | $244,571 | $231,341 | $258,025 | $273,005 | $231,777 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,884 | 15,057 | 15,043 | 15,543 | N/A |
| Deferred Revenues | 104,431 | 100,401 | 120,811 | 118,272 | 137,607 |
| Other Non-Current Liabilities | 811,078 | 801,105 | 789,846 | 750,415 | 679,998 |
| TOTAL | $1,244,746 | $1,252,814 | $1,262,477 | $1,275,560 | $1,165,246 |
| Total Liabilities | $1,489,317 | $1,484,155 | $1,520,502 | $1,548,565 | $1,397,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,823 | 139,697 | 139,321 | 139,220 | 140,663 |
| Common Shares | 140 | 139 | 139 | 140 | 141 |
| Retained earnings | -909,098 | -878,154 | -846,309 | -707,534 | -857,563 |
| Other shareholders' equity | 203,663 | 201,180 | 182,937 | 188,163 | 136,298 |
| TOTAL | $1,606,384 | $1,594,795 | $1,570,411 | $1,684,547 | $1,497,966 |
| Total Liabilities And Equity | $3,095,701 | $3,078,950 | $3,090,913 | $3,233,112 | $2,894,989 |